Infections with Hepatitis B and C Viruses in Dialysis Units Tomasz Ozorowski, Alicja E. Grzegorzewska Medical Science Review - Hepatologia 2007; 7 42-46 aaICID: 485983
Article type: Review article
IC™ Value: 2.88
Abstract provided by Publisher
Hepatitis virus infections are a major infectious concern in dialysis units. In Poland in 2004 the prevalence of HBsAg positivity among dialysis patients was 4.7% and 13.3% were anti- HCV positive. Dialysis patients acquire blood-borne viral infections through contaminated equipment, environmental surfaces or hands or gloves of the staff. HBV infection can be also acquired by
internally contaminated dialysis machine. To reduce risk for transmission of HBV and HCV, infection control measures should be implemented in all dialysis units. They include routine serologic testing of all dialysis patients for antigen HBs, HBs antibodies, HCV antibodies and HCV-RNA. HbsAgpositive
patients should be treated with haemodialysis in a separate room. The standard infection control precautions such as hand hygiene, gloves policy and no sharing of instruments, medication and supplies between patients are the most important regardless of patients’ serological status.